Catalyst Wire Dossier Catalyst Wire Dossier

RETACRIT

EPOETIN ALFA-EPBX · Vifor (International) Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for RETACRIT, covering 2015-07-28 to 2026-07-20. Get the full timeline:

Most recent: EMA Authorised: Retacrit (epoetin zeta) — Pfizer Europe MA EEIG

See pricing